相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Association between Histamine 2 Receptor Antagonist Use and Clostridium difficile Infection: A Systematic Review and Meta-analysis
Imad M. Tleyjeh et al.
PLOS ONE (2013)
Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis
Chun Shing Kwok et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
David W. Eyre et al.
CLINICAL INFECTIOUS DISEASES (2012)
Proton Pump Inhibitor Use and Recurrent Clostridium difficile-associated Disease A Case-control Analysis Matched by Propensity Score
Yong Gil Kim et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2012)
Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial
Oliver A. Cornely et al.
LANCET INFECTIOUS DISEASES (2012)
Efficacy of Fidaxomicin Versus Vancomycin as Therapy for Clostridium difficile Infection in Individuals Taking Concomitant Antibiotics for Other Concurrent Infections
Kathleen M. Mullane et al.
CLINICAL INFECTIOUS DISEASES (2011)
Using Electronic Health Information to Risk-Stratify Rates of Clostridium difficile Infection in US Hospitals
Marya D. Zilberberg et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Development and Validation of a Clostridium difficile Infection Risk Prediction Model
Erik R. Dubberke et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2011)
Fidaxomicin versus Vancomycin for Clostridium difficile Infection
Thomas J. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Persistence of Skin Contamination and Environmental Shedding of Clostridium difficile during and after Treatment of C-difficile Infection
Ajay K. Sethi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)
Stuart H. Cohen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread
Archie C. A. Clements et al.
LANCET INFECTIOUS DISEASES (2010)
Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea
Ji Won Kim et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
K. W. Garey et al.
JOURNAL OF HOSPITAL INFECTION (2008)
Increase in adult Clostrillium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005
Marya D. Zilberberg et al.
EMERGING INFECTIOUS DISEASES (2008)
Clostridium difficile-associated disease in a setting of endemicity:: Identification of novel risk factors
Erik R. Dubberke et al.
CLINICAL INFECTIOUS DISEASES (2007)
Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis
Richard M. Cadle et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Recommendations for surveillance of Clostridium difficile-associated disease
L. Clifford McDonald et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea:: A cohort study during an epidemic in Quebec
J Pépin et al.
CLINICAL INFECTIOUS DISEASES (2005)
Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003:: a changing pattern of disease severity
J Pépin et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
分享论文
